CDDD11-8
Product Specifications
CAS Number
2241659-94-7
Target
FLT|||CDK
Related Pathways
Tyrosine Kinase/Adaptors|||Cell Cycle/Checkpoint|||Angiogenesis
Bioactivity
CDDD11-8 is an orally administered, highly potent and selective CDK9 and FLT3-ITD inhibitor, with K i values of 8 nM and 13 nM, respectively. It effectively reduces the proliferation of leukemia cell lines, showing particular efficacy against those with the FLT3-ITD mutation [1] [2].
Smiles
CC=1C(C=2N3C(=NC2)C=CC(=C3)C4=CC=CC=C4)=NC(N[C@@H]5CC[C@@H](N)CC5)=NC1
Molecular Formula
C24H26N6
Molecular Weight
398.5
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/212215650406367340/T86025
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
HL1-H82E5-200ug 200 µg
Biotinylated Human HLA-DRA1*01:01&HLA-DRB1*04:01 Monomer Protein (Peptide free, MALS verified)
Ask
View Details 
GTR15228403 1 Vial
Lentiviral mouse Fgf21 shRNA (UAS) - Lentiviral mouse Fgf21 shRNA (UAS) plasmid
Ask
View Details 